The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer
Author:
Funder
Inger and John Fredriksens's Foundation for Ovarian Cancer Research
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/20/2/286/392083/mdn591.pdf
Reference26 articles.
1. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study;Eisenkop;Gynecol Oncol,1998
2. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer; the ICON4/AGO-OVAR-2.2 trial;The ICON and AGO Collaborators;Lancet,2003
3. Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer;AGO-OVAR NCIC CTG & EORTC GCG;Int J Gynecol Cancer,2005
4. on behalf of the Doxil Study 30-49 Investigators. Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer;Gordon;Gynecol Oncol,2004
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Secondary cytoreduction in recurrent ovarian cancer- experience from a tertiary care centre in India;Gynecologic Oncology Reports;2024-08
2. Secondary cytoreduction in platinum sensitive relapsed ovarian cancer: an individual patient level meta-analysis;International Journal of Gynecologic Cancer;2023-08-11
3. A review of robotic surgery in the management of recurrent ovarian carcinoma: indication and techniques;European Journal of Gynaecological Oncology;2022
4. The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis;Journal of Ovarian Research;2021-07-13
5. Tratamiento quirúrgico de las recidivas de los tumores epiteliales del ovario;EMC - Ginecología-Obstetricia;2020-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3